CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BAYRY

Larotrectinib monotherapy

Phase 2
BAYER (BAYRY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
BAYRYPhase 2

Larotrectinib monotherapy Phase 2 Est. Readout

Larotrectinib monotherapy
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Differentiated Thyroid Cancer

View Full Landscape
Drug Information

Target Indication

Differentiated Thyroid Cancer

Clinical Trial

NCT05783323

Last updated: 9/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.